Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$12.84 - $17.26 $131,776 - $177,139
-10,263 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$14.61 - $17.59 $225,987 - $272,082
-15,468 Reduced 60.11%
10,263 $154,000
Q3 2020

Nov 09, 2020

SELL
$11.64 - $16.86 $573,491 - $830,675
-49,269 Reduced 65.69%
25,731 $426,000
Q2 2020

Aug 14, 2020

BUY
$7.75 - $22.61 $581,250 - $1.7 Million
75,000 New
75,000 $972,000

Others Institutions Holding TELA

About TELA Bio, Inc.


  • Ticker TELA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 19,157,600
  • Market Cap $55.4M
  • Description
  • TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...
More about TELA
Track This Portfolio

Track Caas Capital Management LP Portfolio

Follow Caas Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Caas Capital Management LP with notifications on news.